Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia
© 2021 Elsevier España, S.L.U. All rights reserved..
Introduction: Severe COVID-19 is associated with hypoxemic bilateral pneumonia that leads to mechanical ventilation in a considerable proportion of patients. To the best of our knowledge, there are no recommendations about the best time to initiate high flow nasal cannula (HFNC).
Patients and methods: Retrospective study of all patients admitted for COVID-19 pneumonia who required HNFO between March 2020 and February 2021. Patients were grouped in early HNFC or late HNFC, according to the modified Kirby index.
Results: 53 patients were included. Forty-four of them were included in the early HFNC and 9 in late HNFC. There were no statistically significant clinical-epidemiological differences. Early use of HFNC was associated with a decrease in the need for intubation (29.5 vs. 66.6%, p = 0.044), hospital stay (18.8 d vs. 36 d, p = 0.022) and mortality (22.7 vs. 55.5%, p = 0.061).
Conclusions: Early HFNC use is associated with a decrease in the need for intubation, mortality and overall hospital stay.
| Errataetall: |
CommentIn: Med Clin (Barc). 2022 Oct 28;159(8):e53. - PMID 34654553 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:158 |
|---|---|
| Enthalten in: |
Medicina clinica (English ed.) - 158(2022), 11 vom: 10. Juni, Seite 540-542 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
García-Pereña, Laura [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 07.11.2022 published: Print-Electronic CommentIn: Med Clin (Barc). 2022 Oct 28;159(8):e53. - PMID 34654553 Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.medcle.2021.05.024 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341565261 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341565261 | ||
| 003 | DE-627 | ||
| 005 | 20231226012055.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.medcle.2021.05.024 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1138.xml |
| 035 | |a (DE-627)NLM341565261 | ||
| 035 | |a (NLM)35634247 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a García-Pereña, Laura |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 07.11.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Med Clin (Barc). 2022 Oct 28;159(8):e53. - PMID 34654553 | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2021 Elsevier España, S.L.U. All rights reserved. | ||
| 520 | |a Introduction: Severe COVID-19 is associated with hypoxemic bilateral pneumonia that leads to mechanical ventilation in a considerable proportion of patients. To the best of our knowledge, there are no recommendations about the best time to initiate high flow nasal cannula (HFNC) | ||
| 520 | |a Patients and methods: Retrospective study of all patients admitted for COVID-19 pneumonia who required HNFO between March 2020 and February 2021. Patients were grouped in early HNFC or late HNFC, according to the modified Kirby index | ||
| 520 | |a Results: 53 patients were included. Forty-four of them were included in the early HFNC and 9 in late HNFC. There were no statistically significant clinical-epidemiological differences. Early use of HFNC was associated with a decrease in the need for intubation (29.5 vs. 66.6%, p = 0.044), hospital stay (18.8 d vs. 36 d, p = 0.022) and mortality (22.7 vs. 55.5%, p = 0.061) | ||
| 520 | |a Conclusions: Early HFNC use is associated with a decrease in the need for intubation, mortality and overall hospital stay | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a HNFC | |
| 650 | 4 | |a Kirby index | |
| 650 | 4 | |a Pneumonia | |
| 700 | 1 | |a Ramos Sesma, Violeta |e verfasserin |4 aut | |
| 700 | 1 | |a Tornero Divieso, María Lucía |e verfasserin |4 aut | |
| 700 | 1 | |a Lluna Carrascosa, Alfonso |e verfasserin |4 aut | |
| 700 | 1 | |a Velasco Fuentes, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Parra-Ruiz, Jorge |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Medicina clinica (English ed.) |d 2015 |g 158(2022), 11 vom: 10. Juni, Seite 540-542 |w (DE-627)NLM308740777 |x 2387-0206 |7 nnns |
| 773 | 1 | 8 | |g volume:158 |g year:2022 |g number:11 |g day:10 |g month:06 |g pages:540-542 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.medcle.2021.05.024 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 158 |j 2022 |e 11 |b 10 |c 06 |h 540-542 | ||